cephalosporin c has been researched along with isepamicin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baltch, AL; Ritz, WJ; Smith, RP; Valdes, JM | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Tanaka, S | 1 |
Abe, M; Imaoka, Y; Kamiyama, Y; Kunii, Y; Masamune, R; Momono, S; Oouchi, K; Toyoda, T; Toyoshima, T; Watanabe, I | 1 |
Beauchamp, D; Kanke, M; Yazaki, T; Yoshiyama, Y | 1 |
Sato, S; Toriya, M; Tsuji, A; Yamaguchi, S | 1 |
Adinolfi, LE; Andreana, A; Ragone, E; Sarnataro, G; Tripodi, MF; Utili, R | 1 |
Barinov, SM; Hasegawa, M; Komlev, VS; Sudo, A; Uchida, A | 1 |
Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH | 1 |
Gopal, R; Hahm, JS; Hahm, KS; Jeong, N; Kim, JY; Lee, JK; Park, SC; Park, Y; Son, BK; Yoo, S | 1 |
1 trial(s) available for cephalosporin c and isepamicin
Article | Year |
---|---|
[Combination use of second generation cephem and isepamicin for the treatment of post-surgical infection of the lower digestive tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefmetazole; Cefotiam; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Intestinal Diseases; Intestines; Male; Middle Aged; Peritonitis; Postoperative Complications; Surgical Wound Infection | 1997 |
8 other study(ies) available for cephalosporin c and isepamicin
Article | Year |
---|---|
In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin | 1990 |
[Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Cefotiam; Cephalosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gentamicins; Humans; Methicillin Resistance; Staphylococcus aureus | 1996 |
Protective effect of ceftriaxone against the nephrotoxicity of isepamicin administered once daily in rats.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Creatinine; Gentamicins; Hexosaminidases; Kidney Cortex; Kidney Diseases; Male; Rats; Rats, Wistar | 1998 |
[Effects of isepamicin and beta-lactam antibiotics on the release of endotoxin from Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Endotoxins; Gentamicins; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins | 1999 |
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Time Factors | 2001 |
High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Cephalosporins; Delayed-Action Preparations; Drug Carriers; Durapatite; Female; Femur; Gentamicins; Microscopy, Electron, Scanning; Nanostructures; Porosity; Prostheses and Implants; Rabbits; Vancomycin | 2004 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software | 2008 |
Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Line; Cephalosporins; Cholelithiasis; Drug Resistance, Bacterial; Drug Synergism; Gentamicins; Humans; Melitten; Molecular Sequence Data; Pseudomonas aeruginosa | 2010 |